Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Learn about the key financial habits for success that can pave the way to wealth. Start building these habits today!
26,788 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
A potential Dow reshuffle could end Nike's long run in the index and swap it for a consumer-facing giant. This articl...
Bitcoin faces a steep uphill climb after last year’s peak left early buyers in the red. Analysts say a near 90% rally...
Bittensor TAO jumped close to 18% over a short window, signaling renewed momentum in AI-focused crypto. This article ...
Salesforce posted a stronger-than-expected quarter, delivering an EPS beat and stronger cash flow. The company unveil...
Nebius Group stock charged higher on Wednesday amid fresh AI cloud developments. This article breaks down the catalys...
Pershing Square seeks an NYSE debut for both its closed-end fund and parent, targeting a $5-$10 billion raise and a B...
Costco's strength goes beyond its membership fees. This article reveals how Kirkland Signature quietly grew into Cost...
AST SpaceMobile has captured attention with a surge tied to high-profile deals. This guide breaks down what the stock...
Celsius shares have fallen more than 50% from their intraday peaks as growth from newly acquired brands accelerates. ...
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
Two COOs rose to the top job in 2024-2026 and reveal what truly matters in the COO-to-CEO transition, from alignment ...